The MRI-linear accelerator consortium: Evidence-based clinical introduction of an innovation in radiation oncology connecting researchers, methodology, data collection, quality assurance, and technical development

MR-Linac Consortium Clinical Steering Committee

Research output: Contribution to journalArticlepeer-review

101 Scopus citations

Abstract

An international research consortium has been formed to facilitate evidence-based introduction of MR-guided radiotherapy (MR-linac) and to address how the MR-linac could be used to achieve an optimized radiation treatment approach to improve patients' survival, local, and regional tumor control and quality of life. The present paper describes the organizational structure of the clinical part of the MR-linac consortium. Furthermore, it elucidates why collaboration on this large project is necessary, and how a central data registry program will be implemented.

Original languageEnglish (US)
Article number215
JournalFrontiers in Oncology
Volume6
Issue numberOCT
DOIs
StatePublished - Oct 13 2016

Keywords

  • Consortium
  • Innovation
  • Linear accelerator
  • MR-linac
  • MRI
  • Radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'The MRI-linear accelerator consortium: Evidence-based clinical introduction of an innovation in radiation oncology connecting researchers, methodology, data collection, quality assurance, and technical development'. Together they form a unique fingerprint.

Cite this